Please login to the form below

Not currently logged in
Email:
Password:

Abbott plans $3bn debt offering

Abbott plans to sell a three-part offering of senior unsecured bond notes, which could range from $3bn to $4bn

Abbott plans to sell a three-part offering of senior unsecured bond notes, which could range from $3bn to $4bn, according to sources.

The offering comprises $750m of five-year notes that may yield 70 basis points more than similar-maturity Treasuries; $1bn of 10-year debt that may, similarly, pay 90 basis points more; and $1.25bn of 30-year bonds that may pay a 122 basis-point spread. A basis point is 0.1 percentage point.

Abbott is tapping the bond market for the first time since February 2009 as investors' concern that Europe's sovereign debt crisis will spread pushes issuance this month to the lowest in a decade.

The Illinois-based pharma company will use proceeds to repay some of its $3.6bn of commercial paper and for general corporate purposes, according to documents filed with the US Securities and Exchange Commission.

The proposed sale follows Abbott's recent steps to buy big parts of Solvay Pharmaceuticals of Belgium and Piramal Healthcare of India.

25th May 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...

Infographics